Use of intravenous bisphosphonates in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems

By Oster Gerry   Lamerato Lois   Glass Andrew   Richert-Boe Kathryn   Lopez Andrea   Chung Karen   Richhariya Akshara   Dodge Tracy   Wolff Greg   Balakumaran Arun   Edelsberg John  

Supportive Care in Cancer, Vol. 22, Iss. 5, 2014-05 ,pp. : 1363-1373

Springer Publishing Company

Access to resources Recommend Favorite

Use of Bisphosphonates in Skeletal Metastasis

By Elomaa Inkeri  

Acta Oncologica, Vol. 39, Iss. 4, 2000-10 ,pp. : 445-454

Informa Healthcare

Access to resources Recommend Favorite

Bisphosphonates in Metastatic Breast Cancer

By Schmid Peter   Possinger Kurt  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 87-93

Springer Publishing Company

Access to resources Recommend Favorite

Bisphosphonates and Breast Cancer Prevention

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 2, 2012-02 ,pp. : 144-150

Bentham Science Publishers

Access to resources Recommend Favorite

Utilization of palliative radiotherapy for breast cancer patients with bone metastases treated with bisphosphonates—Toronto Sunnybrook Regional Cancer Centre experience

By Enright Katherine  

Supportive Care in Cancer, Vol. 12, Iss. 1, 2004-01 ,pp. : 48-52

Springer Publishing Company

Access to resources Recommend Favorite